Recall Record

Woburn, MA, United States

Safecor Health, LLC recalls

7 recalls recorded since 2018, most recently on 13 August 2026. 6 are listed as ongoing. Status and classification are as published by the FDA.

Recalls7
Ongoing (FDA)6
Terminated or completed1
Class I (FDA)0

Ongoing Class II Drugs

Recall started
13 August 2026
Reason
Failed Stability Specifications
Distribution
Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0845-2026, D-0846-2026, D-0844-2026, D-0843-2026, D-0842-2026, D-0841-2026

Ongoing Class II Drugs

Recall started
1 May 2026
Reason
Presence of a Foreign Substance; black particles observed in liquid
Distribution
OH
Initiated
Voluntary: Firm initiated
Recall number
D-0549-2026

Ongoing Class II Drugs

Recall started
30 April 2026
Reason
Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.
Distribution
TX only
Initiated
Voluntary: Firm initiated
Recall number
D-0538-2026

Ongoing Class II Drugs

Recall started
10 October 2025
Reason
Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm.
Distribution
Distributed in Massachusetts
Initiated
Voluntary: Firm initiated
Recall number
D-0214-2026

Ongoing Class II Drugs

Recall started
17 February 2025
Reason
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall numbers
D-0250-2025, D-0253-2025, D-0252-2025, D-0254-2025, D-0251-2025

Ongoing Class II Drugs

Recall started
11 November 2024
Reason
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
Distribution
USA nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0058-2025, D-0059-2025, D-0060-2025, D-0057-2025, D-0056-2025

Terminated Class II Drugs

Recall started
19 October 2023
Terminated
8 November 2024
Reason
CGMP Deviations: Recall due to the absence of USP CGMP compendial requirements.
Distribution
Distributed Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0082-2024

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.